Amanat Acquisition to merge with Corxel Pharmaceuticals in business combination
Amanat Acquisition Corp. signed a definitive business combination agreement to merge with Corxel Pharmaceuticals, Inc. and Corxel Pharmaceuticals Limited. The deal values Corxel at $428 million and implies an equity value of $597 million upon closing.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed